Skip to Main Content

1,346

Views

0

CrossRef citations to date

0

Altmetric

Oncology

Health care resource utilization in 3L + patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinib

Jorge E. Cortesa Georgia Cancer Center at Augusta University, Augusta, GA, USACorrespondence[email protected]
View further author information

,

Delphine Reab Hopital Saint-Louis, APHP, Paris, FranceView further author information

,

Michael J. Mauroc Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information

,

Diana Trand EVERSANA, Burlington, Ontario, Canada

https://orcid.org/0000-0002-4207-7554 View further author information

,

Pearl Wangd EVERSANA, Burlington, Ontario, CanadaView further author information

,

Kejal Jadhave Novartis Pharmaceuticals, East Hanover, NJ, USAView further author information

,

Aurore Yocollyf Novartis Services Inc, East Hanover, NJ, USAView further author information

&

Koji Sasakig MD Anderson Cancer Center, The University of Texas, Houston, TX, USAView further author information